Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use Kumar Jeetendra | May 18, 2021 Basel, Switzerland, 18 May 2021 – Lonza has launched the next generation of its popular Nucleofector® Platform. For more than 20 years, Nucleofector® Technology has led the market as the most effective non-viral cell transfection method, which can be used even for hard-to-transfect cells, such as primary cells and pluripotent stem cells. Now, with an …
